BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 16078824)

  • 1. The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications.
    Lambert DM; Fowler CJ
    J Med Chem; 2005 Aug; 48(16):5059-87. PubMed ID: 16078824
    [No Abstract]   [Full Text] [Related]  

  • 2. Fatty pain cures.
    Imming P
    Chem Biol; 2007 Dec; 14(12):1311-2. PubMed ID: 18096498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and development of endocannabinoid-hydrolyzing enzyme inhibitors.
    Minkkilä A; Saario S; Nevalainen T
    Curr Top Med Chem; 2010; 10(8):828-58. PubMed ID: 20370710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights into endocannabinoid degradation and its therapeutic potential.
    Bari M; Battista N; Fezza F; Gasperi V; Maccarrone M
    Mini Rev Med Chem; 2006 Mar; 6(3):257-68. PubMed ID: 16515464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel natural and synthetic ligands of the endocannabinoid system.
    Hanus LO; Mechoulam R
    Curr Med Chem; 2010; 17(14):1341-59. PubMed ID: 20166928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New metabolically stable fatty acid amide ligands of cannabinoid receptors: Synthesis and receptor affinity studies.
    Urbani P; Cavallo P; Cascio MG; Buonerba M; De Martino G; Di Marzo V; Saturnino C
    Bioorg Med Chem Lett; 2006 Jan; 16(1):138-41. PubMed ID: 16213718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual inhibition of alpha/beta-hydrolase domain 6 and fatty acid amide hydrolase increases endocannabinoid levels in neurons.
    Marrs WR; Horne EA; Ortega-Gutierrez S; Cisneros JA; Xu C; Lin YH; Muccioli GG; Lopez-Rodriguez ML; Stella N
    J Biol Chem; 2011 Aug; 286(33):28723-28728. PubMed ID: 21665953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous cannabinoids: structure and metabolism.
    Bisogno T
    J Neuroendocrinol; 2008 May; 20 Suppl 1():1-9. PubMed ID: 18426492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of the endocannabinoid system in the brain.
    Ramos JA; González S; Sagredo O; Gómez-Ruiz M; Fernández-Ruiz J
    Mini Rev Med Chem; 2005 Jul; 5(7):609-17. PubMed ID: 16026307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoglyceride lipase as an enzyme hydrolyzing 2-arachidonoylglycerol.
    Saario SM; Laitinen JT
    Chem Biodivers; 2007 Aug; 4(8):1903-13. PubMed ID: 17712832
    [No Abstract]   [Full Text] [Related]  

  • 11. Up-regulation of the endocannabinoid system in the uterus of leptin knockout (ob/ob) mice and implications for fertility.
    Maccarrone M; Fride E; Bisogno T; Bari M; Cascio MG; Battista N; Finazzi Agrò A; Suris R; Mechoulam R; Di Marzo V
    Mol Hum Reprod; 2005 Jan; 11(1):21-8. PubMed ID: 15563449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocannabinoid biosynthesis and inactivation, from simple to complex.
    Muccioli GG
    Drug Discov Today; 2010 Jun; 15(11-12):474-83. PubMed ID: 20304091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical enzymes involved in endocannabinoid metabolism.
    Basavarajappa BS
    Protein Pept Lett; 2007; 14(3):237-46. PubMed ID: 17346227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet.
    Starowicz KM; Cristino L; Matias I; Capasso R; Racioppi A; Izzo AA; Di Marzo V
    Obesity (Silver Spring); 2008 Mar; 16(3):553-65. PubMed ID: 18239598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-AG + 2 new players = forecast for therapeutic advances.
    Marrs W; Stella N
    Chem Biol; 2007 Dec; 14(12):1309-11. PubMed ID: 18096497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes.
    De Petrocellis L; Ligresti A; Moriello AS; Allarà M; Bisogno T; Petrosino S; Stott CG; Di Marzo V
    Br J Pharmacol; 2011 Aug; 163(7):1479-94. PubMed ID: 21175579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the endocannabinoid system by organophosphorus nerve agents.
    Nomura DK; Blankman JL; Simon GM; Fujioka K; Issa RS; Ward AM; Cravatt BF; Casida JE
    Nat Chem Biol; 2008 Jun; 4(6):373-8. PubMed ID: 18438404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulators of endocannabinoid enzymic hydrolysis and membrane transport.
    Ho WS; Hillard CJ
    Handb Exp Pharmacol; 2005; (168):187-207. PubMed ID: 16596775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The endocannabinoid system in neurodegeneration.
    Battista N; Fezza F; Finazzi-Agrò A; Maccarrone M
    Ital J Biochem; 2006; 55(3-4):283-9. PubMed ID: 17274532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell biology. Anatomy of prostaglandin signals.
    Stella N
    Science; 2011 Nov; 334(6057):768-9. PubMed ID: 22076368
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.